NAR Breakthrough Article

Total Page:16

File Type:pdf, Size:1020Kb

NAR Breakthrough Article Published online 30 January 2018 Nucleic Acids Research, 2018, Vol. 46, No. 4 1565–1583 doi: 10.1093/nar/gky068 NAR Breakthrough Article Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease Kana Asano1,†, Takeo Suzuki1,*,†, Ayaka Saito1, Fan-Yan Wei2, Yoshiho Ikeuchi3, Tomoyuki Numata4, Ryou Tanaka5, Yoshihisa Yamane5, Takeshi Yamamoto6, Takanobu Goto7, Yoshihito Kishita8,KeiMurayama9, Akira Ohtake10, Yasushi Okazaki8,11, Kazuhito Tomizawa2, Yuriko Sakaguchi1 and Tsutomu Suzuki1,* 1Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan, 2Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan, 3Institute of Industrial Science, University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan, 4Biological Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8566, Japan, 5Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Animal Medical Center, Fuchu, Tokyo 183-8509, Japan, 6Tamaki Laboratory, National Research Institute of Aquaculture, Japan Fisheries Research and Education Agency, Tamaki, Mie 519-0423, Japan, 7Department of Chemistry & Biochemistry, National Institute of Technology, Numazu College, Numazu, Shizuoka 410-8501, Japan, 8Division of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama 350-1240, Japan, 9Department of Metabolism, Chiba Children’s Hospital, Midori-ku, Chiba 266-0007, Japan, 10Department of Pediatrics, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan and 11Division of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama 350-1240, Japan Received December 05, 2017; Revised January 17, 2018; Editorial Decision January 18, 2018; Accepted January 23, 2018 ABSTRACT logical consequences. Taurine starvation resulted in downregulation of ␶ m5U frequency in cultured cells Modified uridine containing taurine, 5-taurinometh and animal tissues (cat liver and flatfish). Strikingly, yluridine (␶ m5U), is found at the anticodon first 5-carboxymethylaminomethyluridine (cmnm5U), in position of mitochondrial (mt-)transfer RNAs (tR- which the taurine moiety of ␶ m5U is replaced with NAs). Previously, we reported that ␶ m5U is absent glycine, was detected in mt-tRNAs from taurine- in mt-tRNAs with pathogenic mutations associated depleted cells. These results indicate that tRNA mod- with mitochondrial diseases. However, biogenesis ifications are dynamically regulated via sensing of and physiological role of ␶ m5U remained elusive. intracellular metabolites under physiological condi- Here, we elucidated ␶ m5U biogenesis by confirm- tion. ing that 5,10-methylene-tetrahydrofolate and taurine are metabolic substrates for ␶ m5U formation cat- alyzed by MTO1 and GTPBP3. GTPBP3-knockout INTRODUCTION cells exhibited respiratory defects and reduced mi- tochondrial translation. Very little ␶ m5U34 was de- RNA molecules contain a wide variety of chemical mod- ifications that are introduced post-transcriptionally. RNA tected in patient’s cells with the GTPBP3 mutation, ␶ 5 modifications confer chemical diversity on simple RNA demonstrating that lack of m U results in patho- molecules, endowing them with a wider range of biological *To whom correspondence should be addressed. Tel: +81 3 5841 8752; Fax: +81 3 5841 0550; Email: [email protected] Correspondence may also be addressed to Takeo Suzuki. Tel: +81 3 5841 1260; Fax: +81 3 5841 0550; Email: t [email protected] †These authors contributed equally to the paper as first authors. C The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] 1566 Nucleic Acids Research, 2018, Vol. 46, No. 4 functions. To date, >130 species of RNA modifications have normally, but failed to efficiently decode the UUG codon been reported in various RNA molecules from all domains efficiently (22), strongly suggesting that inefficient decod- of life (1–4). Many of these modifications were discovered ing by the hypomodified tRNA results in defective trans- in transfer RNAs (tRNAs), and tRNA modifications are lation of protein subunits of respiratory chain complexes. involved in various molecular and physiological functions In addition, ␶m5s2U34 is absent from mt-tRNALys with (5,6). In particular, tRNA modifications at the first (wobble) the A8344G point mutation associated with MERRF (my- position of the anticodon (position 34) play critical roles in oclonus epilepsy associated with ragged red fibers) (23,24). regulating the codon–anticodon interaction at the A-site of The hypomodified mt-tRNALys also lacks the ability to de- ribosome during the decoding process in translation (7). code its cognate codons, leading to defective mitochondrial The mitochondrion is a eukaryotic intracellular organelle translation and respiratory activity (25). The pathogenic that produces adenosine triphosphate (ATP) by oxida- point mutations associated with MELAS and MERRF are tive phosphorylation (OXPHOS). Mitochondria contain thought to prevent recognition by the tRNA-modifying en- their own genome, called mitochondrial DNA (mtDNA), zymes responsible for ␶m5U formation. These findings rep- which encodes 13 essential subunits of the respiratory chain resent the first instance of human disease caused by aberrant complexes, two mt-rRNAs and 22 mt-tRNAs. The mam- RNA modifications (19). Hence, we propose ‘RNA mod- malian mitochondrial genetic code deviates from the uni- opathy’ as a distinct category of human disease. versal code by using four dialectal codons: AUA for Met, A metabolic labeling experiment revealed that extracel- UGA for Trp and AGA and AGG (AGR; R = AorG) lular taurine supplied in the medium is directly incorpo- for the stop signal. The 22 species of mt-tRNAs partici- rated to 5-taurinomethyl groups in mt-tRNAs (17). How- pate in translation of 13 proteins encoded in the mtDNA. ever, a comprehensive understanding of ␶m5U biogenesis RNA modifications in mt-tRNAs play critical roles inac- remains elusive. Based on a genetic study in yeast (26), we curate and efficient translation in mitochondria (8). Previ- previously predicted the tRNA modifying enzymes respon- ously, we mapped all modifications in 22 species of mam- sible for ␶m5s2U34. MTO1 and GTPBP3 are likely to be in- malian mt-tRNAs, and found 15 species of modified nucle- volved in the formation of the 5-taurinomethyl group, while osides at 118 positions (9). Three of the modifications, 5- MTU1 is responsible for the 2-thio group of ␶m5s2U34 in formylcytidine (f5C), 5-taurinomethyluridine (␶m5U) and mt-tRNAs. Genetic mutations in MTU1 were identified in 5-taurinomethyl-2-thiouridine (␶m5s2U) are specific to mt- patients of reversible infantile liver failure (RILF) (27–29). tRNAs. Liver-specific knockout of Mtu1 mice exhibited severe im- f5C is present at the first position of the anticodon in pairment of mitochondrial translation and respiratory ac- mt-tRNAMet (10), and f5C34 plays an essential role in tivities in the hepatocytes, demonstrating that mitochon- translation of the dialectal AUA codon as Met (8,11,12). drial dysfunction due to loss of 2-thiolation of ␶m5s2U34 is We and other groups, recently demonstrated that f5C34 a primary cause of RILF (30). Regarding 5-taurinomethyl is synthesized via consecutive reactions, initiated by 5- modification, exome sequencing identified pathogenic mu- methylcytidine (m5C) formation catalyzed by NSUN3 tations in both MTO1 (31–33)andGTPBP3 (34,35) associ- (13,14), followed by hydroxylation and oxidation of m5Cto ated with hypertrophic cardiomyopathy and lactic acidosis, generate f5C, mediated by ALKBH1 (15,16). Both enzymes indicating that lack of taurine modification results in mi- are required for efficient mitochondrial translation and res- tochondrial dysfunction via a mechanism similar to those piratory activity. We also identified two pathogenic point of MELAS and MERRF. However, it has not been directly mutations in mt-tRNAMet that impair f5C34 formation demonstrated that the frequency of ␶m5(s2)U34 is reduced (13). In addition, loss-of-function mutations in NSUN3 in patients’ cells or tissues. were detected in a patient with symptoms of mitochondrial In regard to the biogenesis of ␶m5U34, we demon- disease (14). Together, these observations indicate that loss strate here that the ␤-carbon of L-serine is a source of of f5C34 results in pathological consequences. the methylene group of ␶m5(s2)U34 via 5,10-methylene- Two taurine-containing uridines are present at the wob- tetrahydrofolate (THF) in one-carbon (1C) metabolism. ble positions of five mt-tRNAs: ␶m5U in the mt-tRNAs for This finding is supported by the observation that the Leu(UUR) and Trp, and ␶m5s2U in the mt-tRNAs for Glu, level of ␶m5(s2)U34 was reduced in cells harboring muta- Lys and Gln (9,17)(Figure1A). These modifications pro- tions in serine hydroxymethyltransferase 2 (SHMT2) and mote accurate decoding of purine-ending codons
Recommended publications
  • Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach
    Mafalda Rita Avó Bacalhau Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach Tese de doutoramento do Programa de Doutoramento em Ciências da Saúde, ramo de Ciências Biomédicas, orientada pela Professora Doutora Maria Manuela Monteiro Grazina e co-orientada pelo Professor Doutor Henrique Manuel Paixão dos Santos Girão e pela Professora Doutora Lee-Jun C. Wong e apresentada à Faculdade de Medicina da Universidade de Coimbra Julho 2017 Faculty of Medicine Establishing the pathogenicity of novel mitochondrial DNA sequence variations: a cell and molecular biology approach Mafalda Rita Avó Bacalhau Tese de doutoramento do programa em Ciências da Saúde, ramo de Ciências Biomédicas, realizada sob a orientação científica da Professora Doutora Maria Manuela Monteiro Grazina; e co-orientação do Professor Doutor Henrique Manuel Paixão dos Santos Girão e da Professora Doutora Lee-Jun C. Wong, apresentada à Faculdade de Medicina da Universidade de Coimbra. Julho, 2017 Copyright© Mafalda Bacalhau e Manuela Grazina, 2017 Esta cópia da tese é fornecida na condição de que quem a consulta reconhece que os direitos de autor são pertença do autor da tese e do orientador científico e que nenhuma citação ou informação obtida a partir dela pode ser publicada sem a referência apropriada e autorização. This copy of the thesis has been supplied on the condition that anyone who consults it recognizes that its copyright belongs to its author and scientific supervisor and that no quotation from the
    [Show full text]
  • MOCHI Enables Discovery of Heterogeneous Interactome Modules in 3D Nucleome
    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press MOCHI enables discovery of heterogeneous interactome modules in 3D nucleome Dechao Tian1,# , Ruochi Zhang1,# , Yang Zhang1, Xiaopeng Zhu1, and Jian Ma1,* 1Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA #These two authors contributed equally *Correspondence: [email protected] Contact To whom correspondence should be addressed: Jian Ma School of Computer Science Carnegie Mellon University 7705 Gates-Hillman Complex 5000 Forbes Avenue Pittsburgh, PA 15213 Phone: +1 (412) 268-2776 Email: [email protected] 1 Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract The composition of the cell nucleus is highly heterogeneous, with different constituents forming complex interactomes. However, the global patterns of these interwoven heterogeneous interactomes remain poorly understood. Here we focus on two different interactomes, chromatin interaction network and gene regulatory network, as a proof-of-principle, to identify heterogeneous interactome modules (HIMs), each of which represents a cluster of gene loci that are in spatial contact more frequently than expected and that are regulated by the same group of transcription factors. HIM integrates transcription factor binding and 3D genome structure to reflect “transcriptional niche” in the nucleus. We develop a new algorithm MOCHI to facilitate the discovery of HIMs based on network motif clustering in heterogeneous interactomes. By applying MOCHI to five different cell types, we found that HIMs have strong spatial preference within the nucleus and exhibit distinct functional properties. Through integrative analysis, this work demonstrates the utility of MOCHI to identify HIMs, which may provide new perspectives on the interplay between transcriptional regulation and 3D genome organization.
    [Show full text]
  • Pathogenic Variants in Glutamyl-Trnagln Amidotransferase Subunits Cause a Lethal Mitochondrial Cardiomyopathy Disorder
    ARTICLE DOI: 10.1038/s41467-018-06250-w OPEN Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder Marisa W. Friederich1, Sharita Timal2,3, Christopher A. Powell4, Cristina Dallabona5, Alina Kurolap6,7, Sara Palacios-Zambrano et al.# 1234567890():,; Mitochondrial protein synthesis requires charging mt-tRNAs with their cognate amino acids by mitochondrial aminoacyl-tRNA synthetases, with the exception of glutaminyl mt-tRNA (mt-tRNAGln). mt-tRNAGln is indirectly charged by a transamidation reaction involving the GatCAB aminoacyl-tRNA amidotransferase complex. Defects involving the mitochondrial protein synthesis machinery cause a broad spectrum of disorders, with often fatal outcome. Here, we describe nine patients from five families with genetic defects in a GatCAB complex subunit, including QRSL1, GATB, and GATC, each showing a lethal metabolic cardiomyopathy syndrome. Functional studies reveal combined respiratory chain enzyme deficiencies and mitochondrial dysfunction. Aminoacylation of mt-tRNAGln and mitochondrial protein trans- lation are deficient in patients’ fibroblasts cultured in the absence of glutamine but restore in high glutamine. Lentiviral rescue experiments and modeling in S. cerevisiae homologs confirm pathogenicity. Our study completes a decade of investigations on mitochondrial aminoacy- lation disorders, starting with DARS2 and ending with the GatCAB complex. Correspondence and requests for materials should be addressed to J.L.K.V.H. (email: [email protected]). #A full list of authors and their affliations appears at the end of the paper. NATURE COMMUNICATIONS | (2018) 9:4065 | DOI: 10.1038/s41467-018-06250-w | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06250-w itochondrial disorders are highly heterogeneous due to pericardial effusion.
    [Show full text]
  • 2014-Platform-Abstracts.Pdf
    American Society of Human Genetics 64th Annual Meeting October 18–22, 2014 San Diego, CA PLATFORM ABSTRACTS Abstract Abstract Numbers Numbers Saturday 41 Statistical Methods for Population 5:30pm–6:50pm: Session 2: Plenary Abstracts Based Studies Room 20A #198–#205 Featured Presentation I (4 abstracts) Hall B1 #1–#4 42 Genome Variation and its Impact on Autism and Brain Development Room 20BC #206–#213 Sunday 43 ELSI Issues in Genetics Room 20D #214–#221 1:30pm–3:30pm: Concurrent Platform Session A (12–21): 44 Prenatal, Perinatal, and Reproductive 12 Patterns and Determinants of Genetic Genetics Room 28 #222–#229 Variation: Recombination, Mutation, 45 Advances in Defining the Molecular and Selection Hall B1 Mechanisms of Mendelian Disorders Room 29 #230–#237 #5-#12 13 Genomic Studies of Autism Room 6AB #13–#20 46 Epigenomics of Normal Populations 14 Statistical Methods for Pedigree- and Disease States Room 30 #238–#245 Based Studies Room 6CF #21–#28 15 Prostate Cancer: Expression Tuesday Informing Risk Room 6DE #29–#36 8:00pm–8:25am: 16 Variant Calling: What Makes the 47 Plenary Abstracts Featured Difference? Room 20A #37–#44 Presentation III Hall BI #246 17 New Genes, Incidental Findings and 10:30am–12:30pm:Concurrent Platform Session D (49 – 58): Unexpected Observations Revealed 49 Detailing the Parts List Using by Exome Sequencing Room 20BC #45–#52 Genomic Studies Hall B1 #247–#254 18 Type 2 Diabetes Genetics Room 20D #53–#60 50 Statistical Methods for Multigene, 19 Genomic Methods in Clinical Practice Room 28 #61–#68 Gene Interaction
    [Show full text]
  • 27Th Trna Conference-Abstractsbook-3
    P1.1 The protein-only RNase P PRORP1 interacts with the nuclease MNU2 in Arabidopsis mitochondria G. Bonnard, M. Arrivé, A. Bouchoucha, A. Gobert, C. Schelcher, F. Waltz, P. Giegé Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France The essential endonuclease activity that removes 5’ leader sequences from transfer RNA precursors is called RNase P. While ribonucleoprotein RNase P enzymes containing a ribozyme are found in all domains of life, another type of RNase P called “PRORP”, for “PROtein-only RNase P”, only composed of protein occurs in a wide variety of eukaryotes, in organelles and the nucleus. Although PRORP proteins function as single subunit enzymes in vitro, we find that PRORP1 occurs in protein complexes and is present in polysome fractions in Arabidopsis mitochondria. The analysis of immuno- precipitated protein complexes identifies proteins involved in mitochondrial gene expression processes. In particular, direct interaction is established between PRORP1 and MNU2 another mitochondrial nuclease involved in RNA 5’ processing. A specific domain of MNU2 and a conserved signature of PRORP1 are found to be directly accountable for this protein interaction. Altogether, results reveal the existence of an RNA 5’ maturation complex in Arabidopsis mitochondria and suggest that PRORP proteins might cooperate with other gene expression regulators for RNA maturation in vivo. 111 P1.2 CytoRP, a cytosolic RNase P to target TLS-RNA phytoviruses 1 1 2 1 A. Gobert , Y. Quan , I. Jupin , P. Giegé 1Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France 1Institut Jacques Monod, CNRS, Université Paris Diderot, Paris, France In plants, PRORP enzymes are responsible for RNase P activity that involves the removal of the 5’ extremity of tRNA precursors.
    [Show full text]
  • Association of Chromosome 19 to Lung Cancer Genotypes and Phenotypes
    Cancer Metastasis Rev DOI 10.1007/s10555-015-9556-2 Association of chromosome 19 to lung cancer genotypes and phenotypes Xiangdong Wang1 & Yong Zhang 1 & Carol L. Nilsson2 & Frode S. Berven3 & Per E. Andrén4 & Elisabet Carlsohn5 & Johan Malm7 & Manuel Fuentes7 & Ákos Végvári6,8 & Charlotte Welinder6,9 & Thomas E. Fehniger6,10 & Melinda Rezeli8 & Goutham Edula11 & Sophia Hober12 & Toshihide Nishimura13 & György Marko-Varga6,8,13 # Springer Science+Business Media New York 2015 Abstract The Chromosome 19 Consortium, a part of the aberrations include translocation t(15, 19) (q13, p13.1) fusion Chromosome-Centric Human Proteome Project (C-HPP, oncogene BRD4-NUT, DNA repair genes (ERCC1, ERCC2, http://www.C-HPP.org), is tasked with the understanding XRCC1), TGFβ1 pathway activation genes (TGFB1, LTBP4) chromosome 19 functions at the gene and protein levels, as , Dyrk1B, and potential oncogenesis protector genes such as well as their roles in lung oncogenesis. Comparative genomic NFkB pathway inhibition genes (NFKBIB, PPP1R13L) and hybridization (CGH) studies revealed chromosome aberration EGLN2. In conclusion, neXtProt is an effective resource for in lung cancer subtypes, including ADC, SCC, LCC, and the validation of gene aberrations identified in genomic SCLC. The most common abnormality is 19p loss and 19q studies. It promises to enhance our understanding of lung gain. Sixty-four aberrant genes identified in previous genomic cancer oncogenesis. studies and their encoded protein functions were further vali- dated in the neXtProt database (http://www.nextprot.org/). Among those, the loss of tumor suppressor genes STK11, Keywords Proteins . Genes . Antibodies . mRNA . Mass MUM1, KISS1R (19p13.3), and BRG1 (19p13.13) is spectrometry .
    [Show full text]
  • Mitochondrial Deafness Alleles Confer Misreading of the Genetic Code
    Mitochondrial deafness alleles confer misreading of the genetic code Sven N. Hobbie, Christian M. Bruell, Subramanian Akshay, Sarath K. Kalapala, Dmitry Shcherbakov, and Erik C. Bo¨ ttger* Institut fu¨r Medizinische Mikrobiologie, Universita¨t Zu¨ rich, Gloriastrasse 32, CH-8006 Zurich, Switzerland Edited by V. Ramakrishnan, Medical Research Council, Cambridge, United Kingdom, and approved January 14, 2008 (received for review August 2, 2007) Despite the fact that important genetic diseases are caused by hurdles to create animal models of pathogenic mtDNA muta- mutant mitochondrial ribosomes, the molecular mechanisms by tions remain formidable (12). In the absence of experimental which such ribosomes result in a clinical phenotype remain largely models for ribosomes of higher eukaryotes, a spontaneous yeast unknown. The absence of experimental models for mitochondrial mutant with a mitochondrial rRNA C1477-to-G alteration con- diseases has also prevented the rational search for therapeutic ferring resistance to paromomycin has been used as a model for interventions. Here, we report on the construction of bacterial the human mitochondrial A1555G deafness mutation (13). How- hybrid ribosomes that contain various versions of the mitochon- ever, this yeast mutant does not show a discernible phenotype in drial decoding region of ribosomal RNA. We show that the patho- translation (13, 14), and yeast mitochondrial rRNA position 1477 genic mutations A1555G and C1494T decrease the accuracy of corresponds to human mitochondrial rRNA position 1493 rather translation and render the ribosomal decoding site hypersuscep- than 1494 [see supporting information (SI) Fig. 5 and compare tible to aminoglycoside antibiotics. This finding suggests misread- with Fig. 1]. We wanted to test whether the prokaryotic A site ing of the genetic code as an important molecular mechanism in in the bacterial ribosome can be modified so as to serve as a disease pathogenesis.
    [Show full text]
  • Mitochondrial Dysfunction and Its Role in Tissue-Specific Cellular Stress
    Review www.cell-stress.com Mitochondrial dysfunction and its role in tissue-specific cellular stress David Pacheu-Grau1,*, Robert Rucktäschel1 and Markus Deckers1,* 1 Department of Cellular Biochemistry, University Medical Center Göttingen, Germany. * Corresponding Authors: David Pacheu-Grau, University Medical Center Göttingen, Department of Cellular Biochemistry, Humboldtallee 23, 37073 Göttingen, Germany. Phone: +49-(0)551-394571; E-mail: [email protected]; Markus Deckers, University Medical Center Göttingen, Department of Cellular Biochemistry, Humboldtallee 23, 37073 Göttingen, Germany. Phone: +49-(0)551-395983; E-mail: [email protected] ABSTRACT Mitochondrial bioenergetics require the coordination of two dif- ferent and independent genomes. Mutations in either genome will affect mi- Received originally: 26.04.2018 tochondrial functionality and produce different sources of cellular stress. De- in revised form: 13.06.2018, Accepted 14.06.2018, pending on the kind of defect and stress, different tissues and organs will be Published 13.07.2018. affected, leading to diverse pathological conditions. There is no curative ther- apy for mitochondrial diseases, nevertheless, there are strategies described that fight the various stress forms caused by the malfunctioning organelles. Keywords: mitochondrial dysfunction, Here, we will revise the main kinds of stress generated by mutations in mito- cellular stress, mitochondrial chondrial genes and outline several ways of fighting this stress. pathology, therapy. Abbreviations: ADOA – autosomal dominant optic atrophy, AROA – autosomal recessive optic atrophy, ARS – aminoacyl-tRNA synthetase, CL – cardiolipin, CRISPR – clustered regularly interspaced short palindromic repeats, LHON – Leber’s hereditary optic neuropathy, mt - mitochondrial OXPHOS – oxidative phosphorylation, ROS – reactive oxygen species. MITOCHONDRIA AND CELL METABOLISM like superoxide and hydrogen peroxide.
    [Show full text]
  • Ncomms7336.Pdf
    ARTICLE Received 18 Jul 2014 | Accepted 21 Jan 2015 | Published 19 Mar 2015 DOI: 10.1038/ncomms7336 OPEN Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution Michal Kovac1,2,*, Carolina Navas3,*, Stuart Horswell4,*, Max Salm4,*, Chiara Bardella1,*, Andrew Rowan3, Mark Stares3, Francesc Castro-Giner1, Rosalie Fisher3, Elza C. de Bruin5, Monika Kovacova6, Maggie Gorman1, Seiko Makino1, Jennet Williams1, Emma Jaeger1, Angela Jones1, Kimberley Howarth1, James Larkin7, Lisa Pickering7, Martin Gore7, David L. Nicol8,9, Steven Hazell10, Gordon Stamp11, Tim O’Brien12, Ben Challacombe12, Nik Matthews13, Benjamin Phillimore13, Sharmin Begum13, Adam Rabinowitz13, Ignacio Varela14, Ashish Chandra15, Catherine Horsfield15, Alexander Polson15, Maxine Tran16, Rupesh Bhatt17, Luigi Terracciano18, Serenella Eppenberger-Castori18, Andrew Protheroe19, Eamonn Maher20, Mona El Bahrawy21, Stewart Fleming22, Peter Ratcliffe23, Karl Heinimann2, Charles Swanton3,5 & Ian Tomlinson1,24 Papillary renal cell carcinoma (pRCC) is an important subtype of kidney cancer with a problematic pathological classification and highly variable clinical behaviour. Here we sequence the genomes or exomes of 31 pRCCs, and in four tumours, multi-region sequencing is undertaken. We identify BAP1, SETD2, ARID2 and Nrf2 pathway genes (KEAP1, NHE2L2 and CUL3) as probable drivers, together with at least eight other possible drivers. However, only B10% of tumours harbour detectable pathogenic changes in any one driver gene, and where present, the mutations are often predicted to be present within cancer sub-clones. We specifically detect parallel evolution of multiple SETD2 mutations within different sub-regions of the same tumour. By contrast, large copy number gains of chromosomes 7, 12, 16 and 17 are usually early, monoclonal changes in pRCC evolution.
    [Show full text]
  • Integration of Mirna and Mrna Co-Expression Reveals Potential
    cells Article Integration of miRNA and mRNA Co-Expression Reveals Potential Regulatory Roles of miRNAs in Developmental and Immunological Processes in Calf Ileum during Early Growth Duy N. Do 1,2, Pier-Luc Dudemaine 1, Bridget E. Fomenky 1,3 and Eveline M. Ibeagha-Awemu 1,* 1 Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, QC J1M 0C8, Canada; [email protected] (D.N.D.); [email protected] (P.-L.D.); [email protected] (B.E.F.) 2 Department of Animal Science, McGill University, Ste-Anne-de-Bellevue, QC H9X 3V9, Canada 3 Département de Sciences Animale, Université Laval, Quebec, QC G1V 0A6, Canada * Correspondence: [email protected]; Tel.: +1-819-780-7249 Received: 13 August 2018; Accepted: 5 September 2018; Published: 11 September 2018 Abstract: This study aimed to investigate the potential regulatory roles of miRNAs in calf ileum developmental transition from the pre- to the post-weaning period. For this purpose, ileum tissues were collected from eight calves at the pre-weaning period and another eight calves at the post-weaning period and miRNA expression characterized by miRNA sequencing, followed by functional analyses. A total of 388 miRNAs, including 81 novel miRNAs, were identified. A total of 220 miRNAs were differentially expressed (DE) between the two periods. The potential functions of DE miRNAs in ileum development were supported by significant enrichment of their target genes in gene ontology terms related to metabolic processes and transcription factor activities or pathways related to metabolism (peroxisomes), vitamin digestion and absorption, lipid and protein metabolism, as well as intracellular signaling.
    [Show full text]
  • Impact of Trna Modifications and Trna-Modifying Enzymes on Proteostasis and Human Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Repositório Institucional da Universidade de Aveiro International Journal of Molecular Sciences Review Impact of tRNA Modifications and tRNA-Modifying Enzymes on Proteostasis and Human Disease Marisa Pereira, Stephany Francisco, Ana Sofia Varanda, Mafalda Santos , Manuel A. S. Santos and Ana Raquel Soares * Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, 3810 Aveiro, Portugal; [email protected] (M.P.); [email protected] (S.F.); sofi[email protected] (A.S.V.); [email protected] (M.S.); [email protected] (M.A.S.S.) * Correspondence: [email protected]; Tel.: +3-512-3424-7229 Received: 31 October 2018; Accepted: 20 November 2018; Published: 24 November 2018 Abstract: Transfer RNAs (tRNAs) are key players of protein synthesis, as they decode the genetic information organized in mRNA codons, translating them into the code of 20 amino acids. To be fully active, tRNAs undergo extensive post-transcriptional modifications, catalyzed by different tRNA-modifying enzymes. Lack of these modifications increases the level of missense errors and affects codon decoding rate, contributing to protein aggregation with deleterious consequences to the cell. Recent works show that tRNA hypomodification and tRNA-modifying-enzyme deregulation occur in several diseases where proteostasis is affected, namely, neurodegenerative and metabolic diseases. In this review, we discuss the recent findings that correlate aberrant tRNA modification with proteostasis imbalances, in particular in neurological and metabolic disorders, and highlight the association between tRNAs, their modifying enzymes, translational decoding, and disease onset. Keywords: transfer RNA; tRNA modifications; tRNA-modifying enzymes; proteostasis; conformational disorders; translation; protein aggregation 1.
    [Show full text]
  • Transcriptome Characterization of Human Mammary Cell Lines Expressing Different Levels of ERBB2 by Serial Analysis of Gene Expression
    1441-1461 26/4/06 13:24 Page 1441 INTERNATIONAL JOURNAL OF ONCOLOGY 28: 1441-1461, 2006 Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression MARIANA LOPES DOS SANTOS1, CAROLINA GONÇALVES PALANCH1, SIBELI SALAORNI1, WILSON ARAUJO DA SILVA Jr2 and MARIA APARECIDA NAGAI1 1Disciplina de Oncologia, Departamento de Radiologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo; 2Departamento de Genética, Faculdade de Medicina de Ribeirão Preto-USP, Ribeirão Preto, Brazil Received October 31, 2005; Accepted December 27, 2005 Abstract. Over-expression of ERBB2, a member of the family Introduction of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis The ERBB2 gene, also known as HER2/NEU, encodes a and chemoresistance to a variety of anticancer drugs. In this 185-kDa transmembrane glycoprotein with intrinsic tyrosine study, aiming to identify differentially-expressed genes kinase activity that belongs to the epidermal growth factor involved in erbB2-mediated transformation of the breast, we receptor (EGFR) family (1). This family of receptor tyrosine generated SAGE libraries from two human mammary cell kinases (RTKs) comprises four members, EGFR (ERBB1), lines, derived from normal luminal cells, expressing different ERBB2 (HER2), ERBB3 and ERBB4 that play important roles levels of erbB2. The parental cell line HB4a expresses basal in several signal transduction pathways regulating cell prolifer- levels and the C5.2 expresses high levels of erbB2. A total of ation, differentiation, cytoskeletal rearrangement and survival 161,632 tags was generated by sequencing, 81,684 from HB4a (1,2).
    [Show full text]